all report title image

Short Bowel Syndrome Market, By Product Type (GLP-2 analogs, Parenteral nutrition, Enteral nutrition, Growth hormones, Anti-diarrheal drugs and other supportive therapies), By End User (Hospitals, Home healthcare settings, Specialty clinics), By Geography (North America, Latin America, Europe, Asia Pacific, Middle East & Africa)

  • Published In : 12 Feb, 2026
  • Code : CMI169
  • Formats :
      Excel and PDF
  • Industry : Pharmaceutical
Ingographics Image
N/A

Table of Contents

  1. Research Objectives and Assumptions

    1. Research Objectives

    2. Assumptions

    3. Abbreviations

  2. Market Preview

    1. Report Description

      1. Market Definition and Scope

    2. Executive Summary

      1. Market Snapshot, By Product Type

      2. Market Snapshot, By End User

      3. Market Snapshot, By Region

    3. Coherent Opportunity Map (COM)

  3. Market Dynamics, Regulations, and Trends Analysis

    1. Market Dynamics

      1. Drivers

      2. Restraints

      3. Market Opportunities

    2. Impact Analysis

    3. Recent Product Launches

    4. Epidemiology

    5. Merger, Acquisition, and Collaboration

    6. Regulatory Scenario

    7. Key Developments

    8. PEST Analysis

    9. Partnership Scenario

    10. Brand and Pricing Analysis

    11. Distributors Landscape

    12. Porters Analysis

    13. Technological Advancements

    14. Key Developments

    15. Market Trend

    16. Future Prospective

    17. Top Market Players by Revenue

  4. Short Bowel Syndrome Market By Product Type, 2026–2033, (US$ Billion)

    1. Introduction

      1. Market Share Analysis, 2026 and 2033 (%)

      2. Y-o-Y Growth Analysis, 2022–2033

      3. Segment Trends

    2. GLP-2 analogs

      1. Introduction

      2. Market Size and Forecast, and Y-o-Y Growth, 2026-2033, (US$ Billion)

    3. Parenteral nutrition

      1. Introduction

      2. Market Size and Forecast, and Y-o-Y Growth, 2026-2033, (US$ Billion)

    4. Enteral nutrition

      1. Introduction

      2. Market Size and Forecast, and Y-o-Y Growth, 2026-2033, (US$ Billion)

    5. Growth hormones

      1. Introduction

      2. Market Size and Forecast, and Y-o-Y Growth, 2026-2033, (US$ Billion)

    6. Anti-diarrheal drugs and other supportive therapies

      1. Introduction

      2. Market Size and Forecast, and Y-o-Y Growth, 2026-2033, (US$ Billion)

  5. Short Bowel Syndrome Market By End User, 2026-2033, (US$ Billion)

    1. Introduction

      1. Market Share Analysis, 2026 and 2033 (%)

      2. Y-o-Y Growth Analysis, 2022–2033

      3. Segment Trends

    2. Hospitals

      1. Introduction

      2. Market Size and Forecast, and Y-o-Y Growth, 2026-2033, (US$ Billion)

    3. Home healthcare settings

      1. Introduction

      2. Market Size and Forecast, and Y-o-Y Growth, 2026-2033, (US$ Billion)

    4. Specialty clinics

      1. Introduction

      2. Market Size and Forecast, and Y-o-Y Growth, 2026-2033, (US$ Billion)

  6. Short Bowel Syndrome Market By Region, 2026-2033, (US$ Billion)

    1. Introduction

      1. Market Share Analysis, By Region, 2026 and 2033 (%)

      2. Y-o-Y Growth Analysis, For Regions, 2022–2033

      3. Regional Trends

    2. North America

      1. Introduction

      2. Market Size and Forecast, and Y-o-Y Growth, By Product Type, en2026-2033, (US$ Billion)

      3. Market Size and Forecast, and Y-o-Y Growth, By End User, 2026-2033, (US$ Billion)

      4. Market Size and Forecast, and Y-o-Y Growth, By Country, 2026-2033, (US$ Billion)

        1. U.S.

        2. Canada

    3. Latin America

      1. Introduction

      2. Market Size and Forecast, and Y-o-Y Growth, By Product Type, 2026-2033, (US$ Billion)

      3. Market Size and Forecast, and Y-o-Y Growth, By End User, 2026-2033, (US$ Billion)

      4. Market Size and Forecast, and Y-o-Y Growth, By Country, 2026-2033, (US$ Billion)

        1. Brazil

        2. Mexico

        3. Argentina

        4. Rest of Latin America

    4. Europe

      1. Introduction

      2. Market Size and Forecast, and Y-o-Y Growth, By Product Type, 2026-2033, (US$ Billion)

      3. Market Size and Forecast, and Y-o-Y Growth, By End User, 2026-2033, (US$ Billion)

      4. Market Size and Forecast, and Y-o-Y Growth, By Country, 2026-2033, (US$ Billion)

        1. U.K.

        2. Germany

        3. Italy

        4. France

        5. Spain

        6. Russia

        7. Benelux

        8. Denmark

        9. Norway

        10. Sweden

        11. Rest of Europe

    5. Asia Pacific

      1. Introduction

      2. Market Size and Forecast, and Y-o-Y Growth, By Product Type, 2026-2033, (US$ Billion)

      3. Market Size and Forecast, and Y-o-Y Growth, By End User, 2026-2033, (US$ Billion)

      4. Market Size and Forecast, and Y-o-Y Growth, By Country, 2026-2033, (US$ Billion)

        1. China

        2. Taiwan

        3. India

        4. Japan

        5. Indonesia

        6. Malaysia

        7. Philippines

        8. Singapore

        9. Australia

        10. South Korea

        11. Rest of Asia Pacific

o    Middle East & Africa

  1. Introduction

  2. Market Size and Forecast, and Y-o-Y Growth, By Product Type, 2026-2033, (US$ Billion)

  3. Market Size and Forecast, and Y-o-Y Growth, By End User, 2026-2033, (US$ Billion)

  4. Market Size and Forecast, and Y-o-Y Growth, By Country, 2026-2033, (US$ Billion)

    1. Bahrain

    2. Kuwait

    3. Oman

    4. Qatar

    5. Saudi Arabia

    6. UAE

    7. Israel

    8. South Africa

    9. North Africa

    10. Central Africa

    11. Rest of the Middle East

  1. Competitive Landscape

    • Takeda Pharmaceutical

      • Company Highlights

      • Product Portfolio

      • Key Highlights

      • Financial Performance

      • Market Strategies

    • Nestlé Health Science

      • Company Highlights

      • Product Portfolio

      • Key Highlights

      • Financial Performance

      • Market Strategies

    • NPS Pharmaceuticals

      • Company Highlights

      • Product Portfolio

      • Key Highlights

      • Financial Performance

      • Market Strategies

  • Ferring Pharmaceuticals

    • Company Highlights

    • Product Portfolio

    • Key Highlights

    • Financial Performance

    • Market Strategies

    • Ipsen

      • Company Highlights

      • Product Portfolio

      • Key Highlights

      • Financial Performance

      • Market Strategies

    • Mallinckrodt Pharmaceuticals

      • Company Highlights

      • Product Portfolio

      • Key Highlights

      • Financial Performance

      • Market Strategies

  1. Section

    1. Research Methodology

      About Us

  • Need a Custom Report?

    We can customize every report - free of charge - including purchasing stand-alone sections or country-level reports

    Customize Now
Logo

Credibility and Certifications

ESOMAR
DUNS Registered

860519526

Clutch
Credibility and Certification
Credibility and Certification

9001:2015

Credibility and Certification

27001:2022

EXISTING CLIENTELE

Joining thousands of companies around the world committed to making the Excellent Business Solutions.

View All Our Clients
trusted clients logo
© 2026 Coherent Market Insights Pvt Ltd. All Rights Reserved.